| Company Name: |
J & K SCIENTIFIC LTD.
|
| Tel: |
18210857532 18210857532 |
| Email: |
jk.info@jkchemical.com |
| Products Intro: |
Product Name:Colestilan
CAS:95522-45-5
Package:100g,1g,25g,5g
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Email: |
inquiries@lgmpharma.com |
| Products Intro: |
Product Name:Colestilan
CAS:95522-45-5
Purity:Typically NLT 98%
|
|
| | Colestilan Basic information |
| Product Name: | Colestilan | | Synonyms: | Colestilan;Colestilan chloride;Colestimide;Epichlorohydrin-2-methylimidazole copolymer;2-(chloromethyl)oxirane,2-methyl-1H-imidazole | | CAS: | 95522-45-5 | | MF: | C6H9N2OX2.Cl | | MW: | 160.603 | | EINECS: | | | Product Categories: | | | Mol File: | 95522-45-5.mol |  |
| | Colestilan Chemical Properties |
| Melting point | >235°C (dec.) | | storage temp. | Room Temperature | | solubility | Insoluble in All solvent tried | | form | Solid | | color | Light Tan to Light Brown |
| | Colestilan Usage And Synthesis |
| Description | Colestimide
was launched in Japan for the treatment of hyperlipidemia
and hypercholesterolemia. It is a newly developed methyl imidazoleepichlorhydrin
copolymer; this anion exchange resin works as a powerful bile
acid sequestrant, thus increasing the rate of conversion of cholesterol to bile
acids in the liver which may lead to enhancement of the rate of LDL removal. In
animal models and humans, Colestimide proved to be more potent than
cholestyramine and seems to be better tolerated. It reduced plasma levels of
total and LDL cholesterol and did not alter HDL and triglyceride levels.
Colestimide can be used in monotherapy or co-administered with HMG-CoA
reductase inhibitors. | | Originator | Mitsubishi (Japan) | | Uses | Colestilan, is a copolymer of 2-methyl-1H-imidazole and epichlorohydrin, and a bile acid sequestrans, that can be used for the treatment of hypercholesterolemia and dyslipidemia. | | Brand name | Cholebine | | in vivo | Colestilan (MCI-196) (0.125 or 0.5 g content per 15 g of the feed; p.o.; 14 days) decreases blood phosphate and urinary phosphorus excretion in rats[3].
Colestilan is able to improve hyperphosphataemia in rats with renal failure induced by adenine administration for 4 weeks[1]. | Animal Model: | 6-week old Wistar male rats[3] | | Dosage: | 0.125 or 0.5 g content per 15 g of the feed | | Administration: | Oral in feed, 14 days | | Result: | Dose dependently decreased blood phosphate and urinary phosphate excretion. |
|
| | Colestilan Preparation Products And Raw materials |
|